Unitree prices STAR IPO at 150.80 yuan as humanoid robots get a public valuation

Humanoid robots now have a priced public-market number, not just a subscription window. On the evening of August 6, Unitree Robotics said its Shanghai STAR Market issue price is 150.80 yuan per share. Yicai, Sina Tech, IT Home, and other Chinese financial outlets carried the same core figures within hours of the company announcement.

That is a different story from last week's issuance-plan coverage. The Hangzhou maker is no longer asking the market to wait for book building. It has a deal price, an implied listing market value near 61 billion yuan, and a strategic allotment list that includes DeepSeek, Tencent, and large state-linked investors. For buyers, sellers, and operators on a humanoid marketplace, the useful question is how that number should change comps for Unitree G1 and H1 inventory before August 10 subscription and the later opening tape.

What Unitree actually priced

Unitree is issuing about 40.45 million new shares, or 10 percent of post-offering capital, under ticker 688836. At 150.80 yuan, coverage puts expected gross proceeds near 6.1 billion yuan and net proceeds near 5.9 billion yuan. The implied listing market value is about 61 billion yuan. One online lot of 500 shares costs about 75,400 yuan.

Those figures sit well above the arithmetic that dominated early August. The prospectus fundraising target was about 4.2 billion yuan against the same share count, which secondary coverage had treated as roughly 104 yuan per share and about a 42 billion yuan floor. The priced deal lands near 45 percent above that fundraising-target math. The announced issue PE is 219.23 times, above the cited industry average of 38.56 times. The company and underwriter also flagged that the 2025 diluted price-to-sales multiple is above peer averages and warned investors about downside risk if the market re-rates after listing.

Strategic allotment covers about 8.09 million shares, or 20 percent of the offer. Reported names include China's social security fund, DeepSeek, China National Petroleum, China Southern Power Grid, China Telecom, Tencent, and CITIC Securities. Coverage of the allotment says DeepSeek plans to subscribe for up to 150 million yuan with a three-year lockup. Treat that roster as deal-structure context, not as proof that any one AI partner stack ships with a used Unitree body.

Why the issue price matters more than the IPO logo

Last week's post was about calendar and prospectus disclosure: shipment volume, margins, profit, and a public tape that did not exist yet. Today's post is about the number secondary dealers can already cite. A profitable Chinese humanoid volume leader is no longer only "heading to STAR Market." It is priced at about 61 billion yuan before retail subscription opens August 10.

That does not mean every G1 or H1 listing should reprice overnight. Public equity value and used-robot value are different assets. A share price embeds growth options, software roadmap, manufacturing capacity, and capital structure. A robot on listings still trades on serial condition, hours, spare parts, software rights, and whether the SKU can move legally in the buyer's market. The IPO number is a valuation anchor. It is not a replacement for duty-cycle proof.

Still, the gap versus the ~42 billion yuan fundraising floor changes negotiation language. Sellers who were already floating "public-market humanoid" language now have a concrete multiple to wave around. Buyers should answer with boring evidence: which model year, which software build, which authorization path, and which tasks the machine actually finished. A 219 times earnings print on the equity side is not a warranty on a dusty research platform in a lab closet.

How this sits next to the FCC gate, LimX, Digit, and Optimus

This is not a rerun of the August 1 subscription story. That piece covered the July 30 issuance plan, August 5 book building, August 10 subscription, and prospectus financials. Today's story is the August 6 priced deal itself: 150.80 yuan, about 61 billion yuan of implied listing value, and a named strategic book that includes DeepSeek and Tencent. Same company. Different event and marketplace proof.

It is also not a rerun of the FCC Covered List story. The Covered List still decides which foreign humanoid and quadruped models can receive fresh U.S. equipment authorization. Unitree's IPO decides how A-share investors price a profitable Chinese volume leader. Keep those screens separate when you compare inventory that can still move in the United States against next-gen SKUs that cannot.

LimX Dynamics already raised nearly 200 million dollars at about a 2.2 billion dollar valuation while lining up Hong Kong. That July story was another Chinese maker racing for public capital. Unitree's priced STAR deal is a different disclosure regime and a different valuation tape. Agility Digit and Figure still hold much of the named Western industrial deployment evidence buyers can cite by plant and task. Tesla is still preparing Optimus production at Fremont for internal use first. Unitree's edge remains volume and list price. The public issue price makes that edge easier to argue about and harder to hand-wave.

What marketplace users should do with this

If you buy or sell humanoid robots on Buy My Robots, use the Unitree issue price as a valuation and provenance checklist on listings:

Is the asking price anchored to the 150.80 yuan / ~61 billion yuan deal, or to real hours, software rights, and spare-parts path?
Can the seller show whether the unit is an already authorized model that can still move in the U.S., or a next-gen SKU blocked from fresh authorization?
Does the listing name transferable software and support contacts, or only "IPO humanoid" language?
For Digit, Figure, Optimus, Atlas, or non-Unitree Chinese platforms nearby, has the seller quietly marked up inventory just because Unitree now has a public valuation?

If you operate a lab, warehouse, or plant, separate capital-market excitement from floor risk. A richer IPO book does not clear cybersecurity, data residency, remote-update, or export-control questions on a networked humanoid. Ask where telemetry goes, who can push firmware, and what happens to support if overseas channels tighten further.

Sellers should lead with evidence the buyer can verify. "Unitree G1, documented hours, transferable software, authorization status confirmed" beats "priced at 150.80 yuan IPO comps." Buyers should treat the issue price as context for negotiation ranges, not as a reason to skip serial-level diligence.

What to watch next

Watch three checkpoints. First, whether August 10 subscription and the later opening tape hold near the 150.80 yuan issue price or force a sharp re-rating that secondary dealers then copy into listing pages. Second, whether Unitree discloses overseas shipment mix after the FCC gate, especially for already authorized models versus blocked revisions. Third, whether used Unitree listings start pairing authorization status and task hours with explicit public-comp language instead of vague "first A-share robot stock" slogans.

Public markets can now quote a humanoid company every trading day. Marketplace value still follows the machine in front of you: which Unitree worked, where, for how long, with which rights still attached.